Solta Medical Reschedules Third Quarter 2012 Results Release and
Conference Call to November 1, 2012 Due to Severe Weather
Conditions
HAYWARD, Calif., Oct. 29, 2012 /PRNewswire/ -- Solta Medical, Inc.
(NASDAQ: SLTM), a global leader in the medical aesthetics market,
today announced that it has rescheduled the release of its
financial results and conference call for the third quarter ended
September 30, 2012, to November 1, 2012 due to the unexpected severe
weather conditions associated with Hurricane Sandy.
The Company will release its third quarter 2012 results before
the market opens on Thursday, November
1, 2012. The Company will host a conference call and
webcast on Thursday, November 1,
2012, at 10:30 a.m. Eastern
Time (7:30 a.m. Pacific) to
discuss the financial results and current corporate
developments. The dial-in number for the conference call is
877-941-6009 for domestic participants and 480-629-9819 for
international participants.
To access the live webcast of the call, go to Solta Medical's
website at www.solta.com and click on Investor Relations. An
archived webcast will also be available at www.solta.com.
About Solta Medical, Inc.
Solta Medical, Inc. is a global leader in the medical aesthetics
market providing innovative, safe and effective solutions for
patients that enhance and expand the practice of medical aesthetics
for physicians. The company offers six aesthetic energy devices to
address a range of issues, including skin resurfacing and
rejuvenation with Fraxel® and Clear + Brilliant™, body contouring
and skin tightening with Liposonix® and Thermage® and acne
reduction with Isolaz® and CLARO™. As the innovator and leader in
fractional laser technology, Fraxel delivers minimally invasive
clinical solutions to resurface aging and sun-damaged skin. Using
similar fractional laser technology, Clear + Brilliant is a unique,
cost-effective treatment to prevent and improve the early signs of
photoaging. For body contouring, Liposonix is a non-surgical
treatment to reduce waist circumference with advanced
high-intensity focused ultrasound (HIFU) technology to permanently
destroy targeted fat beneath the skin. Thermage is an innovative,
non-invasive radiofrequency procedure for tightening and contouring
skin. Isolaz was the first laser or light-based system indicated
for the treatment of inflammatory acne, comedonal acne, pustular
acne and mild-to-moderate inflammatory acne. CLARO is a personal
care acne system that is the first FDA-cleared over-the-counter IPL
device that uses a powerful combination of both heat and light to
clear skin quickly and naturally. More than two million procedures
have been performed with Solta Medical's portfolio of products
around the world. For more information about Solta Medical, call
1-877-782-2286 or log on to www.Solta.com.
© 2012 Solta Medical, Inc. All rights reserved. Thermage,
Fraxel, Isolaz, Clear + Brilliant, CLARO, Liposonix and Solta
Medical are trademarks or registered trademarks of Solta Medical,
Inc. or its subsidiaries.
Web Site: http://www.Solta.com
SOURCE Solta Medical, Inc.